Clinical trials: Mesenchymal Stem Cell-derived Bioactivator for Treating Chronic Wounds
Mesenchymal Stem Cell-derived Bioactivator for Treating Chronic Wounds
Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Non-healing Wounds
Chronic wounds do not heal for prolonged periods of time with the significant financial burden on the healthcare system. It has become increasingly essential to improve our clinical treatments.
- Trial name
- NCT04235868
- Testing
- Stem cell-derived derived pleiotropic factor, fibroblast growth factor
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Chinese PLA General Hospital